Federal law bans Medicare from covering the drugs when used for weight loss, though they usually are covered when used to treat diabetes and cardiovascular disease
The tradeoff is a higher rate of GI adverse events
Pancreatic Cancer Risk GLP-1RA Drugs: Approved Uses, Benefits, and Common Side Effects The EU Food and Drug Administration has approved several GLP-1RA medications, such as exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide, semaglutide, and tripeptide, offering a range of options for patients seeking treatment
- La semaglutida oral es eficaz, segura y bien tolerada en pacientes con DM2, incluso en aquellos con ERD, con los beneficios propios de esta familia de frmacos, lo que puede facilitar la introduccin ms precoz de un arGLP-1 en el manejo de la DM2
This remains speculative and should not be attempted without appropriate medical guidance
doi: 10.1155/2016/8917578 36 ShinSJChungSKimSJLeeEMYooYHKimJWet al